DK1061938T3 - Orale sammensætninger med cytotoksiske proteiner i lav dosis - Google Patents
Orale sammensætninger med cytotoksiske proteiner i lav dosisInfo
- Publication number
- DK1061938T3 DK1061938T3 DK99906246T DK99906246T DK1061938T3 DK 1061938 T3 DK1061938 T3 DK 1061938T3 DK 99906246 T DK99906246 T DK 99906246T DK 99906246 T DK99906246 T DK 99906246T DK 1061938 T3 DK1061938 T3 DK 1061938T3
- Authority
- DK
- Denmark
- Prior art keywords
- low dose
- oral compositions
- cytotoxic proteins
- proteins
- dose cytotoxic
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 231100000433 cytotoxic Toxicity 0.000 title 1
- 230000001472 cytotoxic effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 102000044159 Ubiquitin Human genes 0.000 abstract 1
- 108090000848 Ubiquitin Proteins 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT98MI000356A IT1298442B1 (it) | 1998-02-24 | 1998-02-24 | Composizioni orali a basso dosaggio di proteine citotossiche |
| PCT/EP1999/001068 WO1999043340A1 (en) | 1998-02-24 | 1999-02-18 | Oral compositions at low dosage of cytotoxic proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1061938T3 true DK1061938T3 (da) | 2002-02-11 |
Family
ID=11379051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99906246T DK1061938T3 (da) | 1998-02-24 | 1999-02-18 | Orale sammensætninger med cytotoksiske proteiner i lav dosis |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1061938B1 (da) |
| JP (1) | JP2002504517A (da) |
| AT (1) | ATE208627T1 (da) |
| AU (1) | AU2624499A (da) |
| CA (1) | CA2321717A1 (da) |
| DE (1) | DE69900466T2 (da) |
| DK (1) | DK1061938T3 (da) |
| ES (1) | ES2165727T3 (da) |
| IT (1) | IT1298442B1 (da) |
| PT (1) | PT1061938E (da) |
| WO (1) | WO1999043340A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI991384A1 (it) * | 1999-06-22 | 2000-12-22 | Zetesis Spa | Uso della proteina uk 114 per inibire il rigetto dei trapianti d'organo |
| ITMI20010762A1 (it) * | 2001-04-10 | 2002-10-10 | Zetesis Spa | Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico |
| ITMI20021205A1 (it) * | 2002-06-04 | 2003-12-04 | Pharmaproducts Uk Ltd | Uso di proteine per il trattamento della leishmaniosi |
| FR2842420B1 (fr) * | 2002-07-16 | 2006-07-14 | Rocher Yves Biolog Vegetale | Composition cosmetique comprenant de l'ubiquitine |
| IT201600127428A1 (it) * | 2016-12-16 | 2018-06-16 | Cusani Alberto Bartorelli | Nuova proteina ricombinante uk 114 in forma stabile polimerica per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE628373A (da) * | 1962-02-23 | 1900-01-01 | Phygiene | |
| IT1244879B (it) * | 1990-12-11 | 1994-09-12 | Alberto Bartorelli | Estratti da tessuti animali, utili in terapia e in diagnostica. |
| IT1270618B (it) * | 1994-07-14 | 1997-05-07 | Zetesis Spa | Proteine ad attivita' antitumorale |
-
1998
- 1998-02-24 IT IT98MI000356A patent/IT1298442B1/it active IP Right Grant
-
1999
- 1999-02-18 AU AU26244/99A patent/AU2624499A/en not_active Abandoned
- 1999-02-18 EP EP99906246A patent/EP1061938B1/en not_active Expired - Lifetime
- 1999-02-18 AT AT99906246T patent/ATE208627T1/de not_active IP Right Cessation
- 1999-02-18 DE DE69900466T patent/DE69900466T2/de not_active Expired - Fee Related
- 1999-02-18 CA CA002321717A patent/CA2321717A1/en not_active Abandoned
- 1999-02-18 WO PCT/EP1999/001068 patent/WO1999043340A1/en not_active Ceased
- 1999-02-18 JP JP2000533136A patent/JP2002504517A/ja active Pending
- 1999-02-18 PT PT99906246T patent/PT1061938E/pt unknown
- 1999-02-18 ES ES99906246T patent/ES2165727T3/es not_active Expired - Lifetime
- 1999-02-18 DK DK99906246T patent/DK1061938T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| PT1061938E (pt) | 2002-04-29 |
| WO1999043340A1 (en) | 1999-09-02 |
| CA2321717A1 (en) | 1999-09-02 |
| ATE208627T1 (de) | 2001-11-15 |
| IT1298442B1 (it) | 2000-01-10 |
| DE69900466T2 (de) | 2002-04-04 |
| EP1061938A1 (en) | 2000-12-27 |
| EP1061938B1 (en) | 2001-11-14 |
| ES2165727T3 (es) | 2002-03-16 |
| DE69900466D1 (de) | 2001-12-20 |
| ITMI980356A1 (it) | 1999-08-24 |
| AU2624499A (en) | 1999-09-15 |
| JP2002504517A (ja) | 2002-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200002299T2 (tr) | Epotilon kompozisyonları. | |
| BR9810495A (pt) | Composição farmacêutica | |
| DE69940769D1 (de) | Orale flüssige zusammensetzungen | |
| IL140930A0 (en) | Compounds and compositions for delivering active agents | |
| ATE383169T1 (de) | Komponente und zusammensetzungen zur verabreichung von wirkstoffen | |
| TR200100894T2 (tr) | Aril ikameli propanolamin türevleri, imalat yöntemleri, ilaç maddeleri, kullanımları. | |
| PT1073470E (pt) | Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos | |
| AU7315301A (en) | Compounds and compositions for delivering active agents | |
| MXPA01008611A (es) | Compuestos y composiciones para suministrar agentes activos. | |
| ATE312080T1 (de) | 2-chinolonen enthaltende arzneimittel | |
| ATE387430T1 (de) | Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe | |
| DE60024414T2 (de) | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen | |
| AU2001296865A1 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
| AP1424A (en) | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens. | |
| SE0102843L (sv) | Stabiliserad oral farmaceutisk komposition innehållande jodid och jodat och metod | |
| TR199801861T2 (xx) | Farmas�tik olarak yararl� bile�imler. | |
| DE50005529D1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| IL141236A0 (en) | New oral formulations for 5-ht4 agonists or antagonists | |
| ATE245028T1 (de) | Trimegestone enthaltende pharmazeutische zusammensetzungen | |
| DK1061938T3 (da) | Orale sammensætninger med cytotoksiske proteiner i lav dosis | |
| IL134930A0 (en) | Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing the same | |
| EP1051141A4 (en) | INSULIN-CONTAINING AMYLINE AGONIST PHARMACEUTICAL COMPOSITIONS | |
| BR9914031A (pt) | Composições farmacêuticas micronizadas |